rs147852216

Variant names:

• chr2-47806345-G-A
• rs147852216
• NM_000179.3:c.3788G>A

Your query was ambiguous. Multiple possible variants found:

• chr2-47806345-G-A
• chr2-47806345-G-C
• chr2-47806345-G-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3 BP6 BS1

The NM_000179.3(MSH6):​c.3788G>A​(p.Arg1263His) variant causes a missense change. The variant allele was found at a frequency of 0.000075 in 1,614,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1263C) has been classified as Uncertain significance.

• Frequency:
  • Genomes: 𝑓 0.00011 (0 hom., cov: 33)
  • Exomes 𝑓: 0.000071 (0 hom.)
• Consequence: MSH6 NM_000179.3 missense
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8 B:7 O:1
• Conservation: PhyloP100: 3.90
• Publications: 10 publications found

Genes affected

MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]

FBXO11 (HGNC:13590): (F-box protein 11) This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class. It can function as an arginine methyltransferase that symmetrically dimethylates arginine residues, and it acts as an adaptor protein to mediate the neddylation of p53, which leads to the suppression of p53 function. This gene is known to be down-regulated in melanocytes from patients with vitiligo, a skin disorder that results in depigmentation. Polymorphisms in this gene are associated with chronic otitis media with effusion and recurrent otitis media (COME/ROM), a hearing loss disorder, and the knockout of the homologous mouse gene results in the deaf mouse mutant Jeff (Jf), a single gene model of otitis media. Alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jun 2010]

FBXO11 Gene-Disease associations (from GenCC):

• intellectual developmental disorder with dysmorphic facies and behavioral abnormalities

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

ACMG classification

Our verdict: Likely_benign. The variant received -4 ACMG points.

• PP3: REVEL computational evidence supports a deleterious effect, 0.66
• BP6: Variant 2-47806345-G-A is Benign according to our data. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593. Variant chr2-47806345-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 127593.
• BS1: Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.0000711 (104/1461822) while in subpopulation SAS AF = 0.000777 (67/86256). AF 95% confidence interval is 0.000627. There are 0 homozygotes in GnomAdExome4. There are 74 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
MSH6	NM_000179.3	c.3788G>A	p.Arg1263His	missense_variant	Exon 8 of 10	ENST00000234420.11	NP_000170.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
MSH6	ENST00000234420.11	c.3788G>A	p.Arg1263His	missense_variant	Exon 8 of 10	1	NM_000179.3	ENSP00000234420.5

Frequencies

GnomAD3 genomes AF: 0.000112 AC: 17 AN: 152120 Hom.: 0 Cov.: 33

Gnomad AFR AF: 0.0000724

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.000524

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.000415

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.0000441

Gnomad OTH AF: 0.000478

GnomAD2 exomes AF: 0.000175 AC: 44 AN: 251220 AF XY: 0.000236

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.000318

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.0000440

Gnomad OTH exome AF: 0.000326

GnomAD4 exome AF: 0.0000711 AC: 104 AN: 1461822 Hom.: 0 Cov.: 33 AF XY: 0.000102 AC XY: 74 AN XY: 727204

African (AFR) AF: 0.0000597 AC: 2 AN: 33478

American (AMR) AF: 0.000268 AC: 12 AN: 44716

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 26132

East Asian (EAS) AF: 0.00 AC: 0 AN: 39686

South Asian (SAS) AF: 0.000777 AC: 67 AN: 86256

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53416

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5768

European-Non Finnish (NFE) AF: 0.0000153 AC: 17 AN: 1111976

Other (OTH) AF: 0.0000993 AC: 6 AN: 60394

GnomAD4 genome AF: 0.000112 AC: 17 AN: 152238 Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12 AN XY: 74436

African (AFR) AF: 0.0000722 AC: 3 AN: 41536

American (AMR) AF: 0.000524 AC: 8 AN: 15280

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 3472

East Asian (EAS) AF: 0.00 AC: 0 AN: 5190

South Asian (SAS) AF: 0.000415 AC: 2 AN: 4818

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 10610

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 294

European-Non Finnish (NFE) AF: 0.0000441 AC: 3 AN: 68012

Other (OTH) AF: 0.000473 AC: 1 AN: 2114

Alfa AF: 0.0000502 Hom.: 0

Bravo AF: 0.0000604

ESP6500AA AF: 0.00 AC: 0

ESP6500EA AF: 0.000116 AC: 1

ExAC AF: 0.000157 AC: 19

Asia WGS AF: 0.000289 AC: 1 AN: 3478

EpiCase AF: 0.0000545

EpiControl AF: 0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:8 Benign:7 Other:1

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Lynch syndrome 5 Uncertain:3 Benign:1

May 04, 2017

Counsyl

Significance: Uncertain significance

Review Status: no assertion criteria provided

Collection Method: clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

May 20, 2023

Neuberg Centre For Genomic Medicine, NCGM

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The missense variant c.3788G>A (p.Arg1263His) in the MSH6 gene has been reported previously in individuals affected with Lynch syndrome (Bodian et al., 2014; Terui et al., 2013). This variant is reported with the allele frequency (0.01%) in the gnomAD Exomes and absent in 1000 Genomes. The amino acid Arginine at position 1263 is changed to a Histidine changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen - Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg1263His in MSH6 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. The recent data however suggests that this could be a Likely benign variant with limited evidence. -

Apr 07, 2023

Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

A heterozygous missense substitution (p.Arg1263His) lies in exon 8 of the MSH6 gene and alters a conserved residue in the protein. . The in silico prediction of the variant are possibly damaging by LRT, Mutation Taster and SIFT. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as variant of uncertain significance. -

Jan 08, 2025

Myriad Genetics, Inc.

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered benign. This variant has been observed in conjunction with multiple pathogenic variants, reducing the likelihood this variant itself is pathogenic. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 27363726]. -

not provided Uncertain:2 Benign:2

Dec 05, 2023

Quest Diagnostics Nichols Institute San Juan Capistrano

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The MSH6 c.3788G>A (p.Arg1263His) variant has been reported in individuals with breast cancer (PMIDs: 25186627 (2015) and 33471991 (2021), see also http://databases.lovd.nl/shared/genes/MSH6)), and a Lynch syndrome-associated cancer (PMID: 31391288 (2020)). This variant has also been identified in unaffected individuals (PMIDs: 24728327 (2014), 32980694 (2020), 32885271 (2021), 33471991 (2021), http://databases.lovd.nl/shared/genes/MSH6). The frequency of this variant in the general population, 0.00085 (26/30612 chromosomes in South Asian subpopulation (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is higher than would generally be expected for pathogenic variants in this gene. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -

Jun 01, 2025

CeGaT Center for Human Genetics Tuebingen

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

MSH6: PM1, BS1 -

Mar 23, 2021

GeneDx

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23621914, 27498913, 24728327, 25186627) -

-

Department of Pathology and Laboratory Medicine, Sinai Health System

Significance: Uncertain significance

Review Status: no assertion criteria provided

Collection Method: clinical testing

The MSH6 p.Arg1263His variant was identified in 10 of 1362 chromosomes (frequency: 0.007) from an ancestrally diverse cohort of healthy individuals the literature (Bodian_2014_24728327). The variant was identified in dbSNP (ID: rs147852216) “With Uncertain significance allele”, ClinVar (5x as uncertain significance by GeneDx, Invitae, Color Genomics, Ambry Genetics, ITMI), Clinvitae (3x), and in control databases in 46 of 276952 chromosomes at a frequency of 0.0002 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 1 of 24026 chromosomes (freq: 0.00004), Other in 3 of 6460 chromosomes (freq: 0.0005), Latino in 10 of 34386 chromosomes (freq: 0.0003), European Non-Finnish in 7 of 126488 chromosomes (freq: 0.00006), and South Asian in 25 of 30782 chromosomes (freq: 0.0008) while not observed in the Ashkenazi Jewish, East Asian, and European Finnish populations. The variant was not identified in the Cosmic, MutDB, UMD-LSDB, Zhejiang Colon Cancer Database, Mismatch Repair Genes Variant Database, and Insight Hereditary Tumors Database. The p.Arg1263 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact of the variant His to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and 1 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -

Hereditary cancer-predisposing syndrome Uncertain:1 Benign:2

Dec 24, 2020

Sema4, Sema4

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: curation

- -

Mar 25, 2025

Color Diagnostics, LLC DBA Color Health

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This missense variant replaces arginine with histidine at codon 1263 of the MSH6 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individuals affected with breast cancer (PMID: 25186627, 33471991), but has also been observed in unaffected individuals (PMID: 4728327, 32885271, 32980694, 33471991). This variant has been identified in 47/282612 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -

Apr 06, 2021

Ambry Genetics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not specified Uncertain:1 Other:1

Sep 19, 2013

ITMI

Significance: not provided

Review Status: no classification provided

Collection Method: reference population

- -

Mar 04, 2025

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Endometrial carcinoma;C1833477:Lynch syndrome 5;C5399763:Mismatch repair cancer syndrome 1 Uncertain:1

Oct 31, 2018

Fulgent Genetics, Fulgent Genetics

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Hereditary nonpolyposis colorectal neoplasms Benign:1

Jan 31, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Hereditary cancer Benign:1

Feb 26, 2025

Mendelics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following: it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease, and/or has normal protein function, and/or has lack of segregation with disease, and/or has been detected in co-occurrence with known pathogenic variant, and/or has lack of disease association in case-control studies, and/or is located in a region inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Benign	0.098
BayesDel_addAF	Pathogenic	0.19	D
BayesDel_noAF	Uncertain	0.090
CADD	Uncertain	24
DANN	Pathogenic	1.0
Eigen	Uncertain	0.67
Eigen_PC	Pathogenic	0.68
FATHMM_MKL	Uncertain	0.94	D
M_CAP	Pathogenic	0.30	D
PhyloP100		3.9
ClinPred		0.19	T
GERP RS		5.5
Varity_R		0.28
Mutation Taster		=44/56	disease causing

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs147852216; hg19: chr2-48033484;